WallStreetZenWallStreetZen

NASDAQ: ARCT
Arcturus Therapeutics Holdings Inc Earnings & Revenue

ARCT past revenue growth

How has ARCT's revenue growth performed historically?
Company
-55.69%
Industry
89.94%
Market
19.39%
ARCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ARCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ARCT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ARCT earnings and revenue history

Current Revenue
$124.5M
Current Earnings
-$107.3M
Current Profit Margin
-86.2%

ARCT Return on Equity

Current Company
-38.7%
Current Industry
16.8%
Current Market
28.2%
ARCT's Return on Equity (-38.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ARCT announces earnings.

ARCT Return on Assets

Current Company
-24.7%
Current Industry
3.2%
ARCT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ARCT Return on Capital Employed

Current Company
-39.32%
Current Industry
-42.4%
ARCT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARCT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ARCT$124.53M-$116.03M-$107.30M+47.67%N/A
ATXS$0.00-$81.63M-$81.63MN/AN/A
KALV$0.00-$125.84M-$126.64M-100.00%N/A
SVRA$0.00-$60.60M-$64.49M-100.00%N/A
PRME$591.00k-$186.22M-$204.50MN/AN/A

ARCT earnings dates

Next earnings date
Aug 5, 2024

Arcturus Therapeutics Holdings Earnings & Revenue FAQ

What were ARCT's earnings last quarter?

On Invalid Date, Arcturus Therapeutics Holdings (NASDAQ: ARCT) reported Q1 2024 earnings per share (EPS) of -$1.00, up 152.36% year over year. Total Arcturus Therapeutics Holdings earnings for the quarter were -$26.82 million. In the same quarter last year, Arcturus Therapeutics Holdings's earnings per share (EPS) was $1.91.

If you're new to stock investing, here's how to buy Arcturus Therapeutics Holdings stock.

What was ARCT's earnings growth in the past year?

As of Q3 2024, Arcturus Therapeutics Holdings's earnings has grown year over year. Arcturus Therapeutics Holdings's earnings in the past year totalled -$107.30 million.

What is ARCT's earnings date?

Arcturus Therapeutics Holdings's earnings date is Invalid Date. Add ARCT to your watchlist to be reminded of ARCT's next earnings announcement.

What was ARCT's revenue last quarter?

On Invalid Date, Arcturus Therapeutics Holdings (NASDAQ: ARCT) reported Q1 2024 revenue of $38.01 million up 52.65% year over year. In the same quarter last year, Arcturus Therapeutics Holdings's revenue was $80.29 million.

What was ARCT's revenue growth in the past year?

As of Q3 2024, Arcturus Therapeutics Holdings's revenue has grown -55.69% year over year. This is 145.63 percentage points lower than the US Biotechnology industry revenue growth rate of 89.94%. Arcturus Therapeutics Holdings's revenue in the past year totalled $124.53 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.